•  
  •  
  •  
  •  

2026-07-20 05:45:36

  • Home
  • Commodities
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Stock Report
  • Watch List
Latest News
  • Can Fin Homes Limited Delivers Strong Opening to FY27: Net Profit Rises 20% to ₹268 Crore Driven by Robust Disbursements
  • Punjab & Sind Bank Registers 23.05% Net Profit Surge in Q1 FY27 Powered by Robust Credit Growth and Improving Asset Quality
  • Bhansali Engineering Polymers Limited Marks Strong Start to FY27: Q1 Consolidated Net Profit Surges 42.9% to ₹65.60 Crore
  • Sangam India Ltd Reports Surge in Q1 FY27 Net Profit to ₹4,102 Lakhs
  • Rossari Biotech Limited Posts Steady Q1 FY27 Growth: Net Profit Rises to ₹350.95 Million

Stock Report

  • ixigo Trains & ConfirmTkt Partner with Swiggy to offer On-Train Food Delivery
  • Vidya Wires Limited Q4 FY26 Update: Sales Surge 57.5% Following New Subsidiary Launch
  • Zydus receives final approval from USFDA for Dapagliflozin Tablets, 5 mg and 10 mg
  • Biocon Pharma Ltd receives U.S. FDA Approval for Dapagliflozin Tablets, 5 mg and 10 mg
  • Tejas Networks wins the Golden Peacock Innovative Product/Service Award 2026
  • HTL Ltd secures orders worth Rs. 1366 crores
  • Satin Creditcare Network Limited Q4 & FY26 Update: AUM Crosses ₹15,000 Crore Milestone
  • Angel One Q4 FY26 Business Update: Client Base Reaches 37 Million Amid Record Order Activity
  • Midwest Energy commenced trial production at its Lithium Battery Assembly Line
  • OLX India Appoints Varun Sanghi as Non-Executive Chairman
  • Aurobindo Pharma receives USFDA Approval for Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets
  • Titan Company Limited - Quarterly Update - Q4 FY 2025-26
  • Lupin Announces the Approval of Dapagliflozin Tablets in the United States
  • Ashiana Housing Ltd - Operations Update for Q4-FY'26 & FY'26
  • Manbro Industries Ltd announces strategic acquisition to strengthen its Infrastructure Businesses
  • IKS Health Announces Launch of Audit-Ready Autonomous Coding Capabilities
  • Aurobindo Pharma receives USFDA Approval for Dapagliflozin Tablets, 5 mg and 10 mg
  • RDB Infrastructure and Power Ltd consortium receives NoA
  • Prostarm Info Systems Ltd receives LOA from Solarium Green Energy Ltd
  • Swan Defence and Heavy Industries Ltd receives order from Energy ONE Ltd
  • Mangal Credit and Fincorp Ltd to inaugurate new branch at Bhilwara
  • Dhabriya Polywood Ltd purchases factory premises
  • Supra Pacific Financial Services Ltd Q4 FY26 Business Update: Loan Portfolio Reaches ₹335.63 Crore
  • Inflame Appliances Limited Reports Strong FY26 Performance: Revenue Up 45%
  • Infosys and Harness Announce Strategic Collaboration to Unlock AI Value for Enterprise Transformation and Modernization Programs
  • Shubham Polyspin Limited Announces Major Capacity Expansion at Borisana Unit
  • GAIL and Alpha Gas Sign a Long-Term Charter Party Agreement for an LNG Carrier
  • Arvind SmartSpaces signs its largest high-rise project in Mumbai, offering a top-line potential of Rs. ~2,400 Cr
  • Thomas Cook India strengthens its Foreign Exchange footprint in Assam Inaugurates new outlet in Guwahati
  • Birla Estates clocks over Rs. 1,600 crores in bookings within a month of launch at Birla Arika Phase 2, Gurugram
  • Alkem launches A to Z Daily, an everyday multivitamin supplement for body and mind
  • Ola Electric Announces Readiness of Indigenous 46100 LFP Cell, Advancing Its End ICE Age Vision
  • EFC achieves over 90% occupancy in record time at Sorint Tower, Wakadewadi, Pune
  • GE Shipping contracts to sell its 2003 built Medium Range Tanker 'Jag Pankhi'
  • Refex Industries Bags ₹70.2 Crore Order from Navratna PSU in Steel Sector
  • PNGS Gargi Fashion Jewellery Ltd - Q4FY26 Business Update
  • Unimech Aerospace and Manufacturing Ltd - Q4 FY26 Business Update
  • United Drilling Tools Ltd - Award of Order from ADiL Group
  • LKP Finance Ltd is now Gyftr Limited
  • Persistent among India's Most Sustainable Companies, Signaling Discipline at Scale Ranked 3rd overall and 2nd in the IT and Digital Services sector
  • Alembic Pharmaceuticals Limited announces USFDA Final Approval for Dapagliflozin Tablets, 5 mg and 10 mg
  • Aartech Solonics Limited receives order worth Rs. 1.26 crore
  • Hexaware Ranked #1 in Value for Money in Whitelane Research 2026 Netherlands IT Sourcing Study
  • Tata Steel Reports Record-Breaking FY2026: India Crude Steel Production Hits 23.48 Million Tons
  • Dynacons Secures Prestigious Project from Jammu & Kashmir Bank for ERP Solution
  • MISH Designs Ltd expands Retail Footprint with New Exclusive Brand Outlet at Citadel, Phoenix Mall, Indore
  • Jindal Stainless announces Ranveer Singh as its first-ever Brand Ambassador
  • Lodha Developers Ltd - Q4FY26 Key Operational Updates
  • Kalyan Jewellers India Ltd - Q4FY26 Business Update
  • SDHI Secures India's First Ammonia Dual-Fuel Bulk Carrier Order
  • First
  • 170
  • 171
  • 172
  • Last

Latest Post

  • Can Fin Homes Limited Delivers Strong Opening to FY27: Net Profit Rises 20% to ₹268 Crore Driven by Robust Disbursements
  • Punjab & Sind Bank Registers 23.05% Net Profit Surge in Q1 FY27 Powered by Robust Credit Growth and Improving Asset Quality
  • Bhansali Engineering Polymers Limited Marks Strong Start to FY27: Q1 Consolidated Net Profit Surges 42.9% to ₹65.60 Crore
  • Sangam India Ltd Reports Surge in Q1 FY27 Net Profit to ₹4,102 Lakhs
  • Rossari Biotech Limited Posts Steady Q1 FY27 Growth: Net Profit Rises to ₹350.95 Million

Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025